捅破“精准医疗”泡沫,动了谁的奶酪?

2016-11-03 韩健 科学网韩健的博客

韩健:HudsonAlpha Institute For Biotechnology,研究员没想到,几天前的一篇普通博文“精准医疗”的泡沫被捅破了?!,经微信里大大小小的朋友圈放大后,竟然成了行业里的热门话题。有人称赞,也有人反驳。其实,只要能让大家冷静地思考,我写那篇文章的目的也就达到了。精准医疗是一个吸引人的热门的概念。谁不想精准呢?谁不希望药到病除呢?我的原则是,玩概念者,自己不能被玩弄,更


韩健:HudsonAlpha Institute For Biotechnology,研究员


没想到,几天前的一篇普通博文“精准医疗”的泡沫被捅破了?!,经微信里大大小小的朋友圈放大后,竟然成了行业里的热门话题。有人称赞,也有人反驳。其实,只要能让大家冷静地思考,我写那篇文章的目的也就达到了。


精准医疗是一个吸引人的热门的概念。谁不想精准呢?谁不希望药到病除呢?我的原则是,玩概念者,自己不能被玩弄,更不能去玩弄病人。


概念是一个很好用的东西,有了热门概念,创业者不用太费力就能找到投资,投资者不用太费神就能把热钱投出去,企业不用太费口舌就能把产品和服务推向市场。试想想,如果没有精准医疗这个概念,创业者拿钱多费劲?作为创业者,我深有体会。过去的二十年,我成立了四个公司,最挠头的就是集资。没有好的“概念”,每次集资都要磨破嘴皮,撞破头皮,剥一层皮。


一个好的概念可以迅速吸引社会的兴趣,集聚社会资源,包括政府资源和社会资金。但是有限的资源分配不公就会产生副作用。如果仔细阅读一下我博客里面提到的两篇文章,你就会发现实际上作者担心的是资源浪费的问题。而美国人担心的仅仅是科研经费的浪费问题,他们的泡沫还没有蔓延到伤害病人利益的程度。他们担心的还仅仅是太多的单位,花太多的钱,去重复不必要的临床实验。可是在中国,泡沫已经有侵犯病人利益的危险了。



精准医疗的最终收益者应该是病人。可是至少在现阶段,病人受益非常有限。首先,能够被精准使用的药物非常有限。精准医疗的口号就是把正确的药,在正确的时间,用在正确的病人身上。如果能够使用的药物本身就是有限的(绝大多数国外用于精准医疗的抗肿瘤药物在中国市场都没有),诊断技术上面再打点折扣,科学性(肿瘤的进化和异质性)上再打些折扣,价格上再给些压力,最后能够受益的病人就变成很少数的一些人了。


有人说,精准医疗不仅仅是肿瘤,其它疾病也需要。的确是,我前几天还写文章讲感染性疾病和耐药基因检测更需要精准医疗。可是肿瘤的精准治疗是喊得最响的,进入市场运作做多的,对病人影响最大的,所以我们要关心。


泡沫的产生本不是医疗科研行业的问题,是社会经济大环境的问题。做为一个生物技术领域的从业人员,我们大家都欢迎有更多的钱投向我们的行业。钱多,本不是我们担心的事情。如果我是在国内创业的“局内人”,我是不会去捅破这个泡沫的。不过,看到很多本不是搞精准医疗的人,不懂精准医疗的人,靠着人缘好,靠着会吹,搞到了超多的资源,然后乱买一堆昂贵的仪器,摆出一个干事业的可笑样子,于是我们又忍不住说几句。说几句公道话,因为我知道有许许多多具有真才实学的科学家,他们不会,也不愿意去吹,所以泡沫里的钱他们也没有机会沾光。相反,泡沫的形成会把本来属于他们的经费吸引去了。


我在国内也接触过上百个形形色色的投资人了,绝大多数看项目的也都是留洋的博士,可是决策拍板的则大都不是搞技术的。所以精准医疗这样的概念就变得很方便,因为这个概念可以让投资决策人误认为风险很小,可以放心地投。其实,和所有风险投资一样,关键还是看创业者是否解决了一个实际问题。解决的问题普遍,难度越大,价值也越大。


通常,概念的后面都有利益集团。如果精准医疗这个概念的后面最后受益者不是病人,那概念本身就值得质疑。如果这个泡沫的破裂损害了你的利益,而你又不是病人,那这个问题就复杂了。一个方便的比喻就是地产。地产的最终受益人应该是买房者,可是如果行业的实际受益人是开发商和中介,那是否就有问题了?


概念总有被澄清的一天,如果是泡沫,也总是要破的。只要我们每天在做的是为了最大限度地满足病人的需求,维护病人的利益,我们的工作就是有意义的,迟早会被认可的。我宁可钱少,但是干着有意义的事,也不愿意钱多,干着自己心里没底的事。如果你真想创新创业,你早晚会成为一个有用概念的创造者,也不必为一个别人提出的概念浪费太多宝贵的时间。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-05 hb2008ye
  2. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-05 1e0ece0dm09(暂无匿称)

    谢谢指点学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-04 lovetcm

    精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-04 zhixue

    物极必反

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-04 Lucky❤0909

    口号和实际需要继续缩短距离!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-04 1dd8c52fm63(暂无匿称)

    继续关注!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-04 xiehhtt

    有道理

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-03 QQ713279ab

    很理性,趋势是对的,只是时间的问题!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1403093, encodeId=ea5e14030937a, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Nov 05 06:25:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153487, encodeId=dfb615348e64, content=谢谢指点学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Nov 05 01:24:25 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153397, encodeId=9c6815339e85, content=精准医疗,虽然很重要,也有一定的临床意义,但是过度的炒作确实是有些夸大了,尤其这两年什么公司都说自己是进军医疗公司,虽然在临床上面可以,对大量的金钱测序,但是真正能够有对应的靶点的药物确实非常之少,能用的还就是那一些常用的靶点。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Nov 04 17:37:31 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153299, encodeId=ef4e15329909, content=物极必反, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25101619573, createdName=zhixue, createdTime=Fri Nov 04 09:14:17 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153292, encodeId=0cc015329201, content=口号和实际需要继续缩短距离!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7ea1708670, createdName=Lucky❤0909, createdTime=Fri Nov 04 09:02:32 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153276, encodeId=77c61532e65e, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Nov 04 08:51:43 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153225, encodeId=703015322566, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2dcf1613323, createdName=xiehhtt, createdTime=Fri Nov 04 06:47:06 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153188, encodeId=e09c153188a3, content=很理性,趋势是对的,只是时间的问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/EAA0B8CCF229D6D96848A3C1ADD02B9A/100, createdBy=45aa1721648, createdName=QQ713279ab, createdTime=Thu Nov 03 22:58:37 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153174, encodeId=d85b1531e466, content=假大空!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2291960840, createdName=蓬莱阁, createdTime=Thu Nov 03 22:16:06 CST 2016, time=2016-11-03, status=1, ipAttribution=)]
    2016-11-03 蓬莱阁

    假大空!

    0

相关资讯

盘点:精准医疗助推癌症的治愈

最新一期《福布斯》展望了未来15年影响世界的五大技术——新型计算机架构、基因组学、纳米技术、储能技术以及机器人技术。文章说,随着这些技术相辅相成,共同发展,人类将开始掌控物理世界。其中关于“基因组学”的解释为:2003年人类基因组首次被解码,其相关开支超过30亿美元。到2030年,人类基因组测序技术将日趋完善,成本也将低于100美元。目前,人类已经将基因组学应用于癌症治疗等医疗领域,通

梅斯作为会议媒体参加2016全球精准医疗(中国)峰会12月上海盛大召开

中国精准医疗计划已列入国家“十三五”科技发展重大专项,并上升为国家战略。目前全球精准医疗市场规模已突破600亿美元,2015-2020年期间增速可达15%,是医药行业整体增速的3至4倍。新一代基因测序、基因芯片、IVD体外诊断、液体活检、靶点单抗药物、细胞免疫治疗、大数据等技术日新月异。政策环境的利好、资本市场的青睐、医疗科技的创新为精准医疗产业的发展带来新契机。

韩健:两篇捅破“精准医疗”泡沫的重要文章

九月份有两篇把“精准医疗”推上审判台的文章引起了人们的广泛注意。一篇发表在自然杂志上; 另一篇在新英格兰医学杂志上:两篇文章总结了最近发表的一些肿瘤个体化治疗的临床结果,不过都给出很悲观的评论。第一篇文章认为“精准策略没有给大多数肿瘤病人带来好处”,“肿瘤的精准治疗仅仅是一个待证明的假说”。"...most people with cancer do not benefit from the

未来医疗十大趋势!(下)

分级诊疗势在必行目前中国医疗资源配置不合理,三甲医院“门庭若市”,其他基层医院则“门可罗雀”。那么目前基层医疗机构的具体数量和使用率到底如何?可以通过基层医疗机构数量,诊疗量和病床使用率的横纵向对比初见端倪。首先,依据《中国卫生和计划生育统计年鉴》,从医疗机构数量的角度看,从2000年到2014年,我国医院数量增加了9542家,而基层医疗机构数量减少了82834家。这表明在过去十余年间,从机构

伴随诊断助力癌症精准治疗

同样的疾病采用同样的治疗方案,这种传统的“一揽子治疗”方法如今已被“个体化医疗”逐渐取代。医生利用各种工具将患者分成不同的组,再根据他们的基因组信息来定制相应的疗法或产品,伴随诊断检测正是这样的工具之一。 伴随诊断是一种与靶向药物相关联的体外诊断技术,主要通过检测人体内蛋白、突变基因的表达水平,在不同类型的疾病人群中筛选出最佳用药人群,有针对性地进行个体化医疗。 记者了解到,伴

基因测序如何催动精准医疗迅猛发展

银河证券历时两个多月,对基因测序行业政策环境,技术趋势及行业巨头的商业模式和投资逻辑进行了深入全面的分析,并发布了《基因测序的发展趋势与商业模式——探讨精准医疗系列报告之(一)》的深度调研报告。随着人类基因组测序技术的飞速提升、生物医学分析技术的快速发展和大数据分析工具的日益完善,我们正进入全新的医疗健康时代——精准医疗。精准医疗是一种基于“个人”的定制医疗模式,其以个体的